T45.603

Clinical Causes: Intentional overdose of fibrinolytic or related medications during an assault Use of prescription drugs without medical supervision in a harmful manner Administration of fibrinolysis-affecting drugs as a form of violence or attack Accidental ingestion or misuse of these medications leading to poisoning

Key Symptoms: Unexpected or excessive bleeding, including bleeding gums or blood in urine or stool Bruising or swelling due to bleeding under the skin Signs of internal bleeding, such as abdominal pain or dizziness Low blood pressure and rapid heartbeat in severe cases Weakness, fatigue, or fainting episodes Confusion or altered mental status if bleeding affects the brain

Diagnosis Path: Diagnosing poisoning by fibrinolysis-affecting drugs typically involves a combination of medical history, physical examination, and laboratory tests. These tests may include blood clotting studies such as prothrombin time (PT), activated partial thromboplastin time (aPTT), and specific drug level measurements. Imaging studies may be employed if internal bleeding is suspected. The healthcare provider will also assess for signs of bleeding and analyze any available evidence of assault if relevant.

Treatment Protocols: Managing this type of poisoning requires prompt medical intervention. Treatment strategies may include administration of supportive care, such as intravenous fluids and blood products to control bleeding, and specific antidotes if available (e.g., tranexamic acid or other clot-stabilizing agents). In cases of severe bleeding or internal hemorrhage, surgical or procedural interventions may be necessary. The approach also involves addressing the underlying cause, especially if the poisoning resulted from assault, which might involve legal and psychological support alongside medical treatment.